PeptidePedia The community reference

HOMA-IR (revision 1)

Old revision·00:49, 1 Oct 2024·ApoB_Aurelio

This is an old revision of this page, as it stood at 00:49, 1 Oct 2024, saved by ApoB_Aurelio with the summary new article: laboratory medicine, expansion welcome. It may differ substantially from the current revision, and any error it contains may since have been corrected.
HOMA-IR
Full nameHomeostatic model assessment of insulin resistance
InputsFasting glucose and fasting insulin
Reference methodHyperinsulinaemic-euglycaemic clamp
Topic infobox · conventions

HOMA-IR is an index of insulin resistance derived from a single fasting sample. In its original linear approximation it is the product of fasting glucose and fasting insulin divided by a constant, and it correlates moderately with clamp-derived measures of insulin sensitivity across populations.[1]

Its appeal is that it requires one blood draw rather than a several-hour clamp. Its weakness is that it is a model-derived approximation from two values, inherits the poor standardisation of insulin assays, and describes hepatic rather than peripheral insulin resistance most directly.[2]

References

  1. ^ Matthews DR, Hosker JP, Rudenski AS, et al. "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man." Diabetologia 28(7):412–419 (1985). PMID 3899825.
  2. ^ Wallace TM, Levy JC, Matthews DR. "Use and abuse of HOMA modeling." Diabetes Care 27(6):1487–1495 (2004). PMID 15161807.